© 2014

Molecular Aspects of Botulinum Neurotoxin

  • Keith A. Foster

Part of the Current Topics in Neurotoxicity book series (Current Topics Neurotoxicity, volume 4)

Table of contents

  1. Front Matter
    Pages i-xii
  2. Michel R. Popoff, Chloé Connan
    Pages 35-68
  3. Bal Ram Singh, Tzuu-Wang Chang, Roshan Kukreja, Shuowei Cai
    Pages 69-101
  4. Subramanyam Swaminathan
    Pages 103-127
  5. Matthew Beard
    Pages 151-170
  6. Sheng Chen, Joseph T. Barbieri
    Pages 171-189
  7. Yien Che Tsai, Brian E. Moller, Michael Adler, George A. Oyler
    Pages 191-205
  8. Miia Lindström, Riikka Keto-Timonen, Hannu Korkeala
    Pages 229-258
  9. Susan E. Maslanka
    Pages 259-289
  10. Michael Adler, Nizamettin Gul, Edward Eitzen, George Oyler, Brian Molles
    Pages 291-342
  11. Back Matter
    Pages 343-345

About this book


Currently, there are tremendous advances being made in understanding the basic science of both the structure and function of botulinum neurotoxins. This knowledge is opening up opportunities in regard to both therapeutic uses and treatment and protection options for civil and bio-defense applications. This volume fully evaluates the status of neurotoxin research and exploitation. The book is a multi-authored collection of chapters written by the leading authorities responsible for the current scientific and clinical research that is advancing the understanding and exploitation of the neurotoxins, and is both up to date and authoritative.


botox botulinum neurotoxin botulism dysport neurotoxin complex neurotoxin-associated proteins oculinum recombinant protein therapeutic agent

Editors and affiliations

  • Keith A. Foster
    • 1
  1. 1.Units 4-10Syntaxin Ltd.AbingdonUnited Kingdom

Bibliographic information

Industry Sectors
Health & Hospitals